An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD

Front Immunol. 2021 Feb 23:12:628024. doi: 10.3389/fimmu.2021.628024. eCollection 2021.

Abstract

Background: The neutrophil-to-lymphocyte ratio (NLR) has been investigated in many autoimmune conditions as a biomarker of inflammation and/or disease activity. The role of NLR in AQP4-IgG-positive neuromyelitis optica spectrum disorders (NMOSD) is far from clear. In this study, NLR was evaluated in patients with AQP4-IgG-positive NMOSD at disease onset and its prognostic impact was subsequently assessed.

Methods: In this multicenter study, we retrospectively included all recent/newly diagnosed treatment-naïve patients with AQP4-IgG-positive NMOSD (n=90) from three different countries in Latin America (LATAM): Argentina, Ecuador, and Mexico. NLR was compared between AQP4-IgG-positive NMOSD and healthy controls (HC, n = 365). Demographic, clinical, paraclinical (including imaging), and prognostic data at 12 and 24 months were also evaluated. Multivariate regression analysis was used to describe and identify independent associations between the log-transformed NLR and clinical (relapses and EDSS) and imaging (new/enlarging and/or contrast-enhancing MRI lesions) outcomes.

Results: NLR was higher in NMOSD patients during the first attack compared with HC (2.9 ± 1.6 vs 1.8 ± 0.6; p<0.0001). Regardless of immunosuppressant's initiation at disease onset, NLR remained higher in NMOSD patients at 12 (2.8 ± 1.3; p<0.0001) and 24 (3.1 ± 1.6; p<0.0001) months. No association was found at 12 and 24 months between the log-transformed NLR and the presence of relapses, new/enlarging and/or contrast-enhancing MRI lesions, and/or physical disability.

Conclusions: In this cohort of LATAM patients with AQP4-IgG-positive NMOSD, NLR was abnormally high in attacks but also during follow-up. However, a high NLR was not an independent predictor of clinical or imaging outcomes in our models.

Keywords: Latin America; biomarkers; brain MRI; expanded disability status scale; neuromyelitis optica spectrum disorder; predictors; relapses.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aquaporin 4 / immunology*
  • Argentina
  • Autoantibodies / blood*
  • Ecuador
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Immunosuppressive Agents / therapeutic use
  • Lymphocyte Count
  • Lymphocytes / immunology*
  • Male
  • Mexico
  • Middle Aged
  • Neuromyelitis Optica / blood
  • Neuromyelitis Optica / diagnostic imaging
  • Neuromyelitis Optica / drug therapy
  • Neuromyelitis Optica / immunology*
  • Neutrophils / immunology*
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies
  • Serologic Tests

Substances

  • AQP4 protein, human
  • Aquaporin 4
  • Autoantibodies
  • Immunoglobulin G
  • Immunosuppressive Agents